SGMA

SigmaTron International, Inc. (SGMA) | Rumor.io

SigmaTron International

SGMA

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about SGMA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

May 21

SigmaTron International, Inc. (SGMA) was halted due to market activity.
The company experienced a significant price increase, with some traders reporting gains of over 150%.
Earnings reports showed a decrease in 3rd Quarter Gross Reverse but an increase in Net income.

Generated by AI

Sentiment

Of the messages about SGMA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	83.69% -2
Bearish	—	—	—	16.31% +2

Bullish· May 21

$SGMA has seen significant volume increases, from 200,000 to almost 4 million, indicating strong market interest.
The company's earnings release showed a decrease in 3rd Quarter Gross Reverse, but an increase in Net income, indicating a positive trend.
$SGMA has experienced a 150% gain, making it one of the quickest and most significant gains of some traders' trading lives.

Bearish· Dec 15

$SGMA has broken down from a descending triangle pattern, indicating a bearish reversal.
The market is perceived as corrupt and scam-like, favoring stocks that burn money rather than making it, which is a negative sentiment for $SGMA.
$SGMA's momentum has been lost, and it may return to its previous lows, with some investors even considering it "too cheap" for a potential further decline.

Generated by AI

Topics

Of the messages about SGMA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	4.81%
Controversies	—	—	—	0%
Earnings	—	—	—	1.11%
Macro	—	—	—	45.93%
Technical Analysis	—	—	—	48.15%

Earnings· Dec 11

SigmaTron International's EPS grew from $0.10 to $0.36 in one year.
This rapid earnings growth suggests positive future prospects for the company.
The EPS increase indicates improved profitability for SigmaTron International.

Announcements· May 4

SigmaTron International, Inc. ($SGMA) has announced an agreement with its secured lenders and the sale of a majority position of Wagz, Inc.
The agreement with secured lenders aims to provide financial relief to the company, while the sale of Wagz, Inc. is expected to bring in significant revenue.
The stock price of $SGMA has seen a significant increase, rising by 12.99% to $3.74 in the last 10 minutes, with a high volume of 11 million shares traded.

Technical Analysis· Dec 14

The stock $SGMA has been identified as a potential candidate for a 3-Day Play, with a possible pullback followed by another leg to the upside, respecting MC levels.
The company's fundamentals are seen as supporting the price outlook, with a potential break above 14.30/15, and a bull flag in the hourly chart.
The stock has a high potential for a significant price increase, with a possible catapult to new ATHs, with key levels at $12 and $15, and a potential explosive move higher.

Generated by AI

Community

Of the messages about SGMA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	15.05%
Newcomers	—	—	—	84.95%

Regulars· May 4

SigmaTron International, Inc. has announced an agreement with its secured lenders and a sale of a majority position of Wagz, Inc., resulting in a $900K term loan and amendment of loan agreements with banks costing $465K.
The company's stock price has been impacted by this announcement, with a 12.99% increase in the last 10 minutes and a 47% increase year-to-date.
The sale of Wagz, Inc. is seen as a completion of a disastrous story for SigmaTron International, Inc., which had previously sold the company for $1 and provided a $900K term loan.

Newcomers· Jul 20

The company's sales have increased by $9M YoY, with a 25% jump in stock price after the announcement.
Newcomers are setting their sights on targets of $7.90 and $9.75, with the latter being considered strong resistance.
The company's stock price is up 13% pre-market, with some users setting stop-losses around $4.25 and considering taking profits around $4.80.

Generated by AI

Also Discussed

Investors talking about SGMA also mention

#	Name	Attention
1	Key Tronic CorporationKTCC	0%0
2	Context Therapeutics Inc.CNTX	0%0
3	Ensysce Biosciences, Inc. Common StockENSC	0%0
4	Biofrontera Inc.BFRI	0%0
5	PTPI - Petros Pharmaceuticals, Inc.	——
6	Longeveron Inc. Class A Common StockLGVN	0%0
7	GRTX - Galera Therapeutics, Inc.	——
8	Cumberland Pharmaceuticals Inc.CPIX	0%new
9	Pasithea Therapeutics Corp.KTTA	0%0
10	Immix Biopharma, Inc.IMMX	0.03%+0.03